News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Rhinomed.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX health stocks: Rhinomed rockets 80% after securing first government purchase for COVID-19 Rhinoswabs
Health & Biotech
Rhinomed positioned for growth in billion-dollar nasal tech market, as share price rockets 40pc in a month
Experts
ScoPo’s powerplays: Healthcare hit by ‘Covid exit trade’, but opportunities remain
News
Last Orders: What you might have missed on the ASX today
Health & Biotech
Health Kick Podcast: Investors smell success in Rhinomed’s flu and coronavirus nasal swab technology
News
September Winners Column: Battery metals sentiment has come roaring back
Experts
ScoPo’s health powerplays: ‘We’re buying any pullbacks’
Health & Biotech
Weed Week: Good news from the TGA, but Australia’s CBD industry still lags the global pack
News
Closing Bell: Today’s biggest small cap movers on the ASX
Health & Biotech
Rhinomed soars after company develops new virus nasal swab
Health & Biotech
Weed Week: Moves are afoot in the US to fix a cannabis ‘scheduling’ clash
News
Rise and Shine: What you need to know before the ASX opens
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Scale-up secret sauce: These are the ingredients for medtech growth
Health & Biotech
Health Kick Podcast: Increasing athletic performance and fighting sleep apnea with a simple nose clip
News
Weed Week: COVID-19 drags on sentiment as ASX-listed pot stocks go 0/33
Health & Biotech
